Jowell Global is a Cayman holding company whose China cosmetics and household franchise just spent a year converting itself into a related-party supplement distributor, and the equity still prices that conversion as residual option value rather than as a self-funding retailer. The annual report for year-end 2025 shows sales recovering after two years of decline, yet the same auditor letter that records the rebound also records material uncertainty about going concern. That pairing is the entire debate. A business that can grow the top line while remaining unable to fund itself from operations is not being mispriced as a growth retailer. It is being priced as a claim on a variable-interest structure whose merchandise, cash, and incremental capital all sit with the same controlling circle.
The load-bearing event is not the sales print. It is the November decision to cancel a two million share private placement at $1.40 and replace it with a $2800000 promissory note to Jowell Holdings, the major shareholder, at four percent interest with a three-year maturity. The cancelled placement would have almost doubled the year-end share count and locked in a deep discount to the later tape. Swapping equity for related-party debt preserved the float and avoided an immediate reset of book value per share, but it also made the controlling holder the company's creditor as well as its supplier family. Cash generation did not fund the year. The note did the work that operations refused to do.
The tension sits in the merchandise mix. Health and nutritional supplements almost quadrupled and now dominate reported sales, while cosmetics fell by about one third and household products collapsed by more than four fifths. Gross margin recovered from about one percent to about seven percent on that mix, which is the bull argument in a single clause. Fulfillment expense then more than quadrupled and consumed a large share of the recovered merchandise profit, so the operating loss narrowed without turning into cash. Longrich Group, tied to a major shareholder, supplied almost nine tenths of purchases after supplying about one quarter the year before. The margin story and the captivity story are the same story told from opposite ends of the invoice.
What resolves the argument is observable in the next annual cycle rather than in the tape. Either fulfillment intensity recedes while the supplement mix keeps the merchandise margin, in which case the going-concern paragraph becomes harder to defend, or Longrich terms and promotion intensity give the gross-profit recovery back and the related-party note plus the effective shelf become the only funding path. The current capitalization near $5 million against about $165 million of sales already assumes the second path is the base case. The first path is the only one that turns this residual claim back into an operating equity.